← FDA Drug Approvals (Drugs@FDA)

ELTROMBOPAG OLAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2026-01-14

Drug application

FDA Application #

ANDA219638

Application type

Abbreviated New Drug Application (Generic)

Brand name

ELTROMBOPAG OLAMINE

Generic name

ELTROMBOPAG OLAMINE

Active ingredients

ELTROMBOPAG OLAMINE

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

SOMERSET THERAPS LLC

Manufacturer

Somerset Therapeutics, LLC

First approval

2026-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown